An Open-label Study Evaluating the Resistance Profile of Single Dose Nevirapine(NVP) When Combined With a 4 or 7 Day Course of Combivir (ZDV/3TC) Compared to Single Dose Nevirapine for the Prevention of Mother to Child Transmission (pMTCT) of HIV - Treatment Options Preservation Study (T.O.P.S.)
Phase of Trial: Phase III
Latest Information Update: 01 Nov 2013
At a glance
- Drugs Lamivudine/zidovudine; Nevirapine
- Indications HIV infections; HIV-1 infections
- Focus Therapeutic Use
- Acronyms TOPS
- 31 Aug 2018 Biomarkers information updated
- 14 Jul 2008 The expected completion date for this trial is now 1 Jan 2007.
- 20 Dec 2007 Status changed from recruiting to completed.